Literature DB >> 2055143

Investigation of colonic prostaglandins in carcinogenesis in the rat colon.

A Yamaguchi1, T Ishida, G Nishimura, M Katoh, I Miyazaki.   

Abstract

Large bowel carcinoma was induced in rats by injecting MNNG intrarectally, and changes in the large bowel mucosa prostaglandin (PG) with time were determined. The PGE2 levels of the colonic mucosa in a control group were 20.9 +/- 9.7 (pg/mg total protein) at 5 weeks, 25.5 +/- 9.7 at 10 weeks, 26.5 +/- 18.1 at 20 weeks, and 34.8 +/- 12.7 at 40 weeks. The PGE2 levels in the MNNG-treated group were 44.7 +/- 6.2 at 5 weeks, 43.1 +/- 14.9 at 10 weeks, 70.1 +/- 23.4 at 20 weeks, and 79.7 +/- 54.1 at 40 weeks. The intrinsic PGE2 levels of the noncancerous mucosa were thus significantly higher for the MNNG group than for the control group at all weeks. At 40 weeks, the PGE2 levels of cancer lesions were significantly high compared with those of the noncancerous area. In the cancerous lesions, 6-keto-PGF1 alpha and PGF2 alpha decreased and TXB2 increased significantly at 40 weeks. The observations demonstrated that PGE2 was implicated as a promoter in the development and proliferation of carcinoma in MNNG-induced large bowel carcinogenesis in rats.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2055143     DOI: 10.1007/bf02049897

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  11 in total

1.  Tissue prostanoids as biomarkers for chemoprevention of colorectal neoplasia: correlation between prostanoid synthesis and clinical response in familial adenomatous polyposis.

Authors:  V W Yang; D E Geiman; W C Hubbard; E W Spannhake; L M Hylind; S R Hamilton; F M Giardiello
Journal:  Prostaglandins Other Lipid Mediat       Date:  2000-01       Impact factor: 3.072

2.  Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposis.

Authors:  F M Giardiello; E W Spannhake; R N DuBois; L M Hylind; C R Robinson; W C Hubbard; S R Hamilton; V W Yang
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

3.  Differential expression of cyclooxygenase 2 in human colorectal cancer.

Authors:  J Dimberg; A Samuelsson; A Hugander; P Söderkvist
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

4.  Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2.

Authors:  S Pugh; G A Thomas
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

5.  Subsite-specific risk factors for colorectal cancer: a hospital-based case-control study in Japan.

Authors:  M Inoue; K Tajima; K Hirose; N Hamajima; T Takezaki; T Hirai; T Kato; Y Ohno
Journal:  Cancer Causes Control       Date:  1995-01       Impact factor: 2.506

6.  Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats.

Authors:  C Gustafson-Svärd; I Lilja; O Hallböök; R Sjödahl
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

7.  Prostanoids, ornithine decarboxylase, and polyamines in primary chemoprevention of familial adenomatous polyposis.

Authors:  Francis M Giardiello; Robert A Casero; Stanley R Hamilton; Linda M Hylind; Jill D Trimbath; Deborah E Geiman; Katharine R Judge; Walter Hubbard; G Johan A Offerhaus; Vincent W Yang
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

8.  Effects of high corn oil diet on preneoplastic murine colons: prostanoid production and lipid composition.

Authors:  N M Robblee; R P Bird
Journal:  Lipids       Date:  1994-01       Impact factor: 1.880

9.  The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cells.

Authors:  Durga Prasad Cherukuri; Xiao B O Chen; Anne-Christine Goulet; Robert N Young; Yongxin Han; Ronald L Heimark; John W Regan; Emmanuelle Meuillet; Mark A Nelson
Journal:  Exp Cell Res       Date:  2007-06-22       Impact factor: 3.905

10.  Inhibitory effect of NS-398, a selective cyclooxygenase-2 inhibitor, on azoxymethane-induced aberrant crypt foci in colon carcinogenesis of F344 rats.

Authors:  N Yoshimi; K Kawabata; A Hara; K Matsunaga; Y Yamada; H Mori
Journal:  Jpn J Cancer Res       Date:  1997-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.